3Helms MW, Prescher JA, Cao YA, et al. IL-12 enhances efficacy and shortens enrichment time in cytokine-induced killer cell immunotherapy [ J ]. Cancer Immunol Immunother, 2010,59 (9) : 1325-1334.
4HiSltl L, Rieser C, Papesh C, et al. Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic ceils [J]. J Urol, 1999,161(3):777-782.
5Albertsson PA, Basse PH, Hokland M, et al. NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity[ J ]. Trends Immunol, 2003,24( 11 ) : 603-609.
6I Oguz A, Unal D, Tasdemir A, et al. Lack of any association be- tween blood groups and lung cancer, independent of histology[ J]. Asian Pac J Cancer Prey, 2013,14( 1 ) :453456.
7Esposito S. Immune system and surgical site infection[J]. J Chc- mother, 2001,13( 1 ) :12-16.
8Becker Y. Molecular immunological approaches to biotherapy of human cancers-a review, hypothesis and implications [ J ]. Anti- cancer Res, 2006,26 (2A) :1113-1134.
